Rapid, serial, non-invasive quantification of Pseudomonas aeruginosa in live mice with a selectable marker-free autoluminescent strain
Shuai Wang,Wei Yu,Zhiyong Liu,Xiaoyin Cai,Sheng Zeng,Jingran Zhang,Yamin Gao,Yaoju Tan,Zhizhong Cao,Lingmin Guo,H.M. Adnan Hameed,Shahzad Akbar Khan,Zafran Khan,Xirong Tian,Cuiting Fang,Md Mahmudul Islam,Sanjeep Sapkota,Ping Guan,Jinxing Hu,Jianxiong Liu,Nanshan Zhong,Tianyu Zhang
DOI: https://doi.org/10.1016/j.bios.2020.112396
IF: 12.545
2020-10-01
Biosensors and Bioelectronics
Abstract:<p><em>Pseudomonas aeruginosa</em> is an increasingly prevalent pathogen that has become a serious health concern due to an increasing incidence of multidrug-resistant (MDR) hospital-acquired infections. The emergence of MDR-<em>P. aeruginosa</em> coupled with shrinking antibiotic pipelines has increased the demand for new antimicrobials and therapeutics. An effective tool for drug screening both <em>in vitro</em> and <em>in vivo</em> can facilitate the discovery of drugs and regimens for treating <em>P. aeruginosa</em> infection. Here, for the first time, we combined the mini-Tn7 system and Xer/<em>dif</em> recombinase system to construct a stable and <u>s</u>electable marker-<u>f</u>ree <u>a</u>uto<u>l</u>uminescent <em><u>P</u>. <u>a</u>eruginosa</em> (SfAlPa) by one step. Afterwards, <em>in vitro</em> and <em>in vivo</em> activities of several antibiotics including amikacin, biapenem, levofloxacin and polymyxin B were assessed using SfAlPa. This study demonstrated that the use of SfAlPa could significantly facilitate rapid real-time evaluating the activities of compounds. Compared to prevailing methods, this method reduces the time, effort, animals and costs consumed in the discovery of new drugs against <em>P. aeruginosa</em>. Additionally, the methodology described in this study could be easily modified for construction of selectable marker-free reporter strain in other Gram-negative bacteria.</p>
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology